The historical rank and industry rank for Austar Lifesciences's Net Margin % or its related term are showing as below:
HKSE:06118'
s Net Margin % Range Over the Past 10 Years
Min: -9.89 Med: 0.9 Max: 13.76
Current: 1.07
HKSE:06118's Net Margin % is ranked better than 51.65% of 819
companies
in the Medical Devices & Instruments industry
Industry Median: 0.02
vs HKSE:06118: 1.07
Austar Lifesciences Net Margin % Historical Data
The historical data trend for Austar Lifesciences's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Austar Lifesciences's Net Margin %
For the Medical Devices subindustry, Austar Lifesciences's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Austar Lifesciences's Net Margin % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Austar Lifesciences's Net Margin % distribution charts can be found below:
* The bar in red indicates where Austar Lifesciences's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Austar Lifesciences (HKSE:06118) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Austar Lifesciences Net Margin % Related Terms
Thank you for viewing the detailed overview of Austar Lifesciences's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Austar Lifesciences Ltd is a China-based company engaged in providing engineering solutions to pharmaceutical manufacturers and research institutes. The business activity of the group is operated through Liquid and Bioprocess Systems; Clean Room and Automation Control and Monitoring Systems; Powder and Solid Systems; Good Manufacturing Practice (GMP) Compliance Services; Life Science Consumables; and Distribution and Agency of Pharmaceutical Equipment segments. It derives the majority of revenue from the Liquid and Bioprocess System segment which is involved in providing solutions in pharmaceutical and water systems to treat water. The geographical business presence of the firm is seen across China and in other countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:06118 has been successfully added to your 